HEPATITIS C AND ADDICTION: Retention rate and side effects in a prospective trial on hepatitis C treatment with pegylated interferon alpha‐2a and ribavirin in opioid‐dependent patients
暂无分享,去创建一个
K. Thau | B. Winklbaur | G. Fischer | C. Matzenauer | N. Ebner | C. Wanner | Crispa Aeschbach Jachmann